Insider · CIK 0001681643
Huda Y Zoghbi
Files at REGN (REGENERON PHARMACEUTICALS, INC.). First filing Oct 17, 2023, latest Aug 12, 2026.
In brief
Huda Y Zoghbi files SEC Form 4 as director at REGN (REGENERON PHARMACEUTICALS, INC.). Since Oct 17, 2023, Huda Y Zoghbi has reported 0 open-market buys worth $0 and 4 open-market sells worth $3.8M, the latest filed on Aug 12, 2026.
A track record needs three past buys with six months of prices behind them; Huda Y Zoghbi has 0, so none is measured yet.
The newest scored trade: sold $640k of REGN on Aug 10, 2026, filed Aug 12, 2026, scored 18 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $1.9M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
REGN: REGENERON PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 18Weak | REGENERON PHARMACEUTICALS, INC. | $640k 800 shares | -32% | +49% from low-0% from high | |
| 30Weak | REGENERON PHARMACEUTICALS, INC. | $1.3M 1,638 shares | -49% | +62% from low-4% from high | |
| 30Weak | REGENERON PHARMACEUTICALS, INC. | $1.0M 1,117 shares | -47% | +33% from low0% from high | |
| 13Weak | REGENERON PHARMACEUTICALS, INC. | $850k 1,000 shares | -45% | +23% from low-1% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 10, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | 800 0.00% of outstanding | $640k | Aug 10, 2026 | none |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | 1,638 0.00% of outstanding | $1.3M | Feb 19, 2026 | none |
| Jan 2, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | 1,117 0.00% of outstanding | $1.0M | Jan 2, 2024 | $850k |
| Oct 13, 2023 | REGN REGENERON PHARMACEUTICALS, INC. | 1,000 0.00% of outstanding | $850k | Oct 13, 2023 | none |
Transactions
Every row this insider has filed, 26 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +800 | $376.69 | $301k | 2,503 | Aug 12, 2026 |
| Aug 10, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -800 | $800.00 | $640k | 1,703 | Aug 12, 2026 |
| Aug 10, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -800 | $0.00 | $0 | 0 | Aug 12, 2026 |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +1,638 | $376.69 | $617k | 3,341 | Feb 23, 2026 |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -49 | $774.68 | $38k | 3,292 | Feb 23, 2026 |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -50 | $775.50 | $39k | 3,242 | Feb 23, 2026 |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -53 | $778.47 | $41k | 3,189 | Feb 23, 2026 |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -208 | $779.55 | $162k | 2,981 | Feb 23, 2026 |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -331 | $780.45 | $258k | 2,650 | Feb 23, 2026 |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -209 | $781.28 | $163k | 2,441 | Feb 23, 2026 |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -298 | $782.10 | $233k | 2,143 | Feb 23, 2026 |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -220 | $783.29 | $172k | 1,923 | Feb 23, 2026 |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -160 | $784.45 | $126k | 1,763 | Feb 23, 2026 |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -56 | $785.61 | $44k | 1,707 | Feb 23, 2026 |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -4 | $790.00 | $3,160 | 1,703 | Feb 23, 2026 |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -1,638 | $0.00 | $0 | 800 | Feb 23, 2026 |
| Jan 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | AGrant or award Common Stock | +155 | $0.00 | $0 | 1,703 | Jan 6, 2026 |
| Jan 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +1,962 | $0.00 | $0 | 1,962 | Jan 6, 2026 |
| Jan 2, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +1,117 | $391.92 | $438k | 2,364 | Jan 4, 2024 |
| Jan 2, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,117 | $900.00 | $1.0M | 1,247 | Jan 4, 2024 |
| Jan 2, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | AGrant or award Common Stock10b5-1 | +135 | $0.00 | $0 | 1,382 | Jan 4, 2024 |
| Jan 2, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -1,117 | $0.00 | $0 | 0 | Jan 4, 2024 |
| Jan 2, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | AGrant or award Non-Qualified Stock Option (right to buy)derivative10b5-1 | +1,607 | $0.00 | $0 | 1,607 | Jan 4, 2024 |
| Oct 13, 2023 | REGN REGENERON PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +1,000 | $391.92 | $392k | 2,247 | Oct 17, 2023 |
| Oct 13, 2023 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,000 | $850.00 | $850k | 1,247 | Oct 17, 2023 |
| Oct 13, 2023 | REGN REGENERON PHARMACEUTICALS, INC. | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -1,000 | $0.00 | $0 | 1,117 | Oct 17, 2023 |
Questions about Huda Y Zoghbi
Answered from the filings on this page, as of the latest one.
Is Huda Y Zoghbi buying or selling?
In the last 12 months Huda Y Zoghbi reported 0 open-market buys worth $0 and 2 open-market sells worth $1.9M on SEC Form 4; the latest was sold $640k of REGN on Aug 10, 2026. Grants, option exercises and tax withholding are not counted.
How did Huda Y Zoghbi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Huda Y Zoghbi has 0.
Where does Huda Y Zoghbi file Form 4?
Huda Y Zoghbi has filed Form 4 at REGN (REGENERON PHARMACEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.